IRCT20200428047228N1招募中3 期
Evaluation of the efficiency and safety of favipiravir + hydroxychloroquine drug regimen in comparison with hydroxychloroquine in hospitalized patients with covid-19
Quality Improvement of Intensive Care Research Center- Shahid Beheshti University0 个研究点目标入组 50 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •a-Respiratory Rate(RR)=30 /min
- •b-SpO2<93% on room air
- •c-PaO2/FIO2<300
- •d-CT scan Involvement>50%
- •e-Diagnosis confirmed by CPR or CT scan
- •f-Age more than 18 years
排除标准
- •a-G6PD Deficiency
- •b-QT interval more than 450 milliseconds
- •c-myasthenia gravis
- •d-Pregnancy- Breast Feeding
- •e-Severe Renal or Hepatic Failure
研究者
相似试验
招募中
2 期
Effectiveness of favipiravir in comparison with Tenofovir Alafenamid in patients with COVID-19COVID-19.COVID-19U07.1IRCT20150808023559N23Ardabil University of Medical Sciences100
已完成
不适用
Investigation on the efficacy and safety of favipiravir in patients who are infected or strongly suspected of being infected with Ebola virusEbola virus diseaseJPRN-UMIN000016101ational Center for Global Health and Medicine5
进行中（未招募）
1 期
An Investigation of the Efficacy and Safety of Favipiravir in COVID-19 Patients without PneumoniaCOVID-19 Patients without PneumoniaEUCTR2020-005214-18-LTVilnius University Hospital Santaros klinikos75
进行中（未招募）
1 期
Clinical trial of Favipiravir treatment of patients with COVID-19EUCTR2020-002728-35-HUHungarian Ministry of Innovation and Technology - Representative: Hecrin Consortium150
进行中（未招募）
1 期
An Investigation of the Efficacy and Safety of Favipiravir in COVID-19 Patients with Mild PneumoniaCOVID-19 Patients with Mild PneumoniaEUCTR2020-005128-12-LTVilnius University Hospital Santaros klinikos96